- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03446729
Enhancing Memory to Facilitate Weight Loss: Tracking, Recording and Coaching (TRAC)
February 20, 2018 updated by: Kerri Boutelle, University of California, San Diego
The objective of this application is to pilot test and evaluate the acceptability and efficacy of a program to facilitate weight loss by enhancing memory for a recently consumed meal.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Once enrolled, all participants will receive behavioral weight loss treatment.
Treatment will be 12 weeks in duration and will consist of 7 sessions.
The content of sessions will provide the main elements described in behavioral therapy programs for obesity, based on empirical literature.
Participants will be provided handouts, and the handout content will be based on our clinic treatment manual and published behavior therapy protocols.
The program will be administered in individual 30-60-min sessions with a behavioral coach meeting every other week.
This program emphasizes self-monitoring of food intake.
It also emphasizes gradual weight loss, increasing physical activity, and improving diet through permanent lifestyle changes.
Program topics include: self-monitoring of eating behavior, physical activity, changing the home environment and nutrition education.
All treatment sessions will be conducted by licensed clinical health psychologists or psychology doctoral level students with experience in leading weight loss interventions.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participant must be overweight (BMI between 25-40)
- Participant must be between the ages of 18-55
- Participant can read at a minimum of an 5th grade level in English
- Participant is willing to participate and to commit to 12 weeks of treatment and attendance at assessments
Exclusion Criteria:
- Participant is unable to exercise (ex., due to physical or medical reasons)
- Major psychiatric disorder diagnoses, including an eating disorder
- Diagnoses of a serious current physical disease (such as diabetes) for which physician supervision of diet is needed
- Participant who takes medications that would influence weight and eating, or cognitive functioning, such as attention, concentration, or mental status
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Memory Self Monitoring (MSM)
Intervention: Guided self-help Behavioral Weight Loss.
The MSM group is assigned to self-monitor in "habit books" what they consume in their previous meal immediately prior to each meal, similar to other studies exploring the effect of episodic meal memory on food intake.
|
Guided self-help Behavioral Weight Loss including 7 visits over 12 weeks.
The treatment content includes self-monitoring, healthy eating, stimulus control, increasing physical activity, reducing sedentary activity, planning ahead for high-risk situations, and relapse prevention.
The 7 visits are conducted with a behavioral coach to give participants educational materials and to promote accountability.
The behavioral coach's role in the gshBWL program is to measure participant weight, collect self-monitoring booklets, clarify materials, and problem-solve barriers to adherence.
Other Names:
|
ACTIVE_COMPARATOR: Caloric Self Monitoring (CSM)
Intervention: Guided self-help Behavioral Weight Loss.
The CSM group is assigned to self-monitor what food they consume, and the associated caloric content after each meal in their "habit books" in line with traditional BWL self-monitoring.
|
Guided self-help Behavioral Weight Loss including 7 visits over 12 weeks.
The treatment content includes self-monitoring, healthy eating, stimulus control, increasing physical activity, reducing sedentary activity, planning ahead for high-risk situations, and relapse prevention.
The 7 visits are conducted with a behavioral coach to give participants educational materials and to promote accountability.
The behavioral coach's role in the gshBWL program is to measure participant weight, collect self-monitoring booklets, clarify materials, and problem-solve barriers to adherence.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Attendance
Time Frame: Post-Treatment (12 weeks following baseline)
|
The number of treatment visits attended
|
Post-Treatment (12 weeks following baseline)
|
Attrition
Time Frame: Change from baseline at an average of 12 weeks
|
The percentage of participant attrition from each treatment arm
|
Change from baseline at an average of 12 weeks
|
Self-Monitoring Adherence
Time Frame: Post-Treatment (12 weeks following baseline)
|
The number of days that participants self-monitor
|
Post-Treatment (12 weeks following baseline)
|
Acceptability
Time Frame: Measured at an average of 12 weeks following baseline
|
Average of likert ratings of self-monitoring method, was it "easier," "more helpful," or "more convenient" than any methods participants may have used to self-monitor in the past
|
Measured at an average of 12 weeks following baseline
|
Weight Change
Time Frame: Change from baseline at an average of 12 weeks and 24 weeks
|
Weight and height will be combined to report BMI in kg/m^2
|
Change from baseline at an average of 12 weeks and 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Working Memory
Time Frame: Change from baseline at an average of 12 weeks and 24 weeks
|
Digit Span: scaled total forward and backward score
|
Change from baseline at an average of 12 weeks and 24 weeks
|
Food specific memory
Time Frame: Change from baseline at an average of 12 weeks and 24 weeks
|
A food version of the California Verbal Learning Test.
Sum of words recalled across the five recall trials of list A (high calorie food, low calorie food, neutral words) as a measure of global index of verbal learning ability.
|
Change from baseline at an average of 12 weeks and 24 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Restraint
Time Frame: Change from baseline at an average of 12 weeks and 24 weeks
|
Restraint subscale from the Three Factor Eating Questionnaire
|
Change from baseline at an average of 12 weeks and 24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 2, 2014
Primary Completion (ACTUAL)
December 3, 2015
Study Completion (ACTUAL)
December 3, 2015
Study Registration Dates
First Submitted
February 8, 2018
First Submitted That Met QC Criteria
February 20, 2018
First Posted (ACTUAL)
February 27, 2018
Study Record Updates
Last Update Posted (ACTUAL)
February 27, 2018
Last Update Submitted That Met QC Criteria
February 20, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 131518
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsNot yet recruitingOverweight and Obesity | Overweight, Childhood | Overweight, Infant
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
-
National Taiwan University HospitalCompleted
Clinical Trials on Guided Self-Help Behavioral Weight Loss
-
Yale UniversityCompleted
-
Stanford UniversityNational Institute of Mental Health (NIMH)Completed
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Rutgers, The State University of New JerseyCompletedDepression | Parkinson's DiseaseUnited States
-
University of California, San DiegoHRSA/Maternal and Child Health BureauCompletedPediatric ObesityUnited States
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Binge EatingUnited States
-
Medical College of WisconsinNational Cancer Institute (NCI); University of ChicagoCompleted
-
University of CologneEli Lilly and CompanyCompletedAttention-Deficit/Hyperactivity DisorderGermany
-
University of CologneEli Lilly and CompanyCompletedAttention-Deficit/Hyperactivity DisorderGermany
-
Yale UniversityNational Eating Disorders AssociationRecruitingBinge-Eating Disorder | Binge EatingUnited States